Trial intelligence / Profile preview

Phase II Study of Panflu H5N1 Vaccine in Healthy Adults

NCT00535665Phase 2Completed

Sponsor
Sinovac Biotech Ltd.
Start
Sep 2007
Modality
Monoclonal Antibodies
01

Overview

A Phase 2 trial of Panflu in avian influenza (HPAI), sponsored by Sinovac Biotech Ltd.. Started Sep 2007; status: completed.

02

Drugs

Panflu
03

Conditions

avian influenza (HPAI)

Beyond the preview

Go deeper on NCT00535665.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00535665.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call